Table 3. Dose adjustment of direct oral anticoagulants in non-valvular atrial fibrillation.
Direct oral anticoagulant | Clinical factors | Dose adjustment |
---|---|---|
Apixaban | At least two of: • serum creatinine ≥133 micromol/L • age ≥80 years • weight ≤60 kg |
5 mg twice a day to 2.5 mg twice a day |
Rivaroxaban | At least one of: • CrCl 30–49 mL/min • combination with dual antiplatelet therapy |
20 mg daily to 15 mg daily |
Dabigatran | At least one of: • CrCl 30–50 mL/min • age ≥75 years • combination with dual antiplatelet therapy |
150 mg twice a day to 110 mg twice a day |
CrCl creatinine clearance
Source: reference 3